NetworkNewsBreaks – Genprex Inc. (NASDAQ: GNPX)
Post# of 231
(Total Views: 325)
Posted On: 03/01/2021 3:35:49 PM
NetworkNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Announces Participation Schedule for March Investor Conferences
Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced its plans to participate in two virtual investor conferences in the month of March. These include the Sachs 14th Annual European Life Sciences CEO Forum taking place March 10-12, as well as the 33rd Annual Roth Conference scheduled to be held from March 15-17, 2021. The company’s president and CEO, Rodney Varner, will lead Genprex’s presentations and will be available for one-on-one meetings with investors throughout the conferences. Interested parties should visit https://nnw.fm/fTwV1 and https://nnw.fm/Q2RT4 to register. The presentations will be available for replay on the company’s website for a period of time following the events.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced its plans to participate in two virtual investor conferences in the month of March. These include the Sachs 14th Annual European Life Sciences CEO Forum taking place March 10-12, as well as the 33rd Annual Roth Conference scheduled to be held from March 15-17, 2021. The company’s president and CEO, Rodney Varner, will lead Genprex’s presentations and will be available for one-on-one meetings with investors throughout the conferences. Interested parties should visit https://nnw.fm/fTwV1 and https://nnw.fm/Q2RT4 to register. The presentations will be available for replay on the company’s website for a period of time following the events.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)